4.5 Article

Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation

Journal

VACCINE
Volume 29, Issue 28, Pages 4593-4600

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2011.04.052

Keywords

African swine fever; Asfarviridae; Pigs; Protection; Immunisation

Funding

  1. Wellcome Trust (Animal Health in the Developing World Initiative)
  2. DEFRA [SE1512]
  3. BBSRC
  4. EU Network of Excellence, EPI-ZONE [FOOD-CT-2006-016236]
  5. Spanish Research Council
  6. BBSRC [BBS/E/I/00001439] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [BBS/E/I/00001191, BBS/E/I/00001003, BBS/E/I/00001439] Funding Source: researchfish

Ask authors/readers for more resources

African swine fever (ASF) is an acute haemorrhagic disease of domestic pigs for which there is currently no vaccine. We showed that experimental immunisation of pigs with the non-virulent OURT88/3 genotype I isolate from Portugal followed by the closely related virulent OURT88/1 genotype I isolate could confer protection against challenge with virulent isolates from Africa including the genotype I Benin 97/1 isolate and genotype X Uganda 1965 isolate. This immunisation strategy protected most pigs challenged with either Benin or Uganda from both disease and viraemia. Cross-protection was correlated with the ability of different ASFV isolates to stimulate immune lymphocytes from the OURT88/3 and OURT88/1 immunised pigs. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available